Gemmer Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Gemmer Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3	Closed	–	–	1265
2021 Q4	$0	Hold	3	–	–	﹤0.01%	1299
2021 Q3	$0	Hold	3	–	–	﹤0.01%	1348
2021 Q2	$0	Hold	3	–	–	﹤0.01%	1520
2021 Q1	$0	Hold	3	–	–	﹤0.01%	1489
2020 Q4	$0	Hold	3	–	–	﹤0.01%	1451
2020 Q3	$0	Hold	3	–	–	﹤0.01%	1373
2020 Q2	$0	Hold	3	–	–	﹤0.01%	1346
2020 Q1	$0	Hold	3	–	–	﹤0.01%	1337
2019 Q4	$0	Hold	3	–	–	﹤0.01%	1392
2019 Q3	$0	Hold	3	–	–	﹤0.01%	1428
2019 Q2	$0	Hold	3	–	–	﹤0.01%	1410
2019 Q1	$0	Hold	3	–	–	﹤0.01%	1412
2018 Q4	$0	Hold	3	–	–	﹤0.01%	1386
2018 Q3	$0	Hold	3	–	–	﹤0.01%	1428
2018 Q2	$0	Hold	3	–	–	﹤0.01%	1430
2018 Q1	$0	Hold	3	–	–	﹤0.01%	1471
2017 Q4	$0	Sell	3 -80	-96%	-$4.39K	﹤0.01%	1248
2017 Q3	$4K	Hold	83	–	–	﹤0.01%	1012
2017 Q2	$4K	Hold	83	–	–	﹤0.01%	992
2017 Q1	$3K	Hold	83	–	–	﹤0.01%	1093
2016 Q4	$4K	Hold	83	–	–	﹤0.01%	976
2016 Q3	$3K	Hold	83	–	–	﹤0.01%	1063
2016 Q2	$2K	Buy	83 +3	+4%	+$97	﹤0.01%	1159
2016 Q1	$3K	Hold	80	–	–	﹤0.01%	963
2015 Q4	$5K	Hold	80	–	–	﹤0.01%	843
2015 Q3	$3K	Hold	80	–	–	﹤0.01%	978
2015 Q2	$5K	Hold	80	–	–	﹤0.01%	845
2015 Q1	$5K	Hold	80	–	–	﹤0.01%	888
2014 Q4	$5K	Hold	80	–	–	﹤0.01%	859
2014 Q3	$3K	Buy	+80	New	+$2.83K	﹤0.01%	1033

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Gemmer Asset Management's IONS Position: Q1 2022 in Review

Gemmer Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2022, closing a stake of 3 shares.

Gemmer Asset Management first reported a position in IONS in Q3 2014 and held it in 30 quarters. The position peaked at $5K in Q4 2015. 332 funds tracked by Wall St. Rank hold IONS as of Q1 2022.

Gemmer Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Gemmer Asset Management sold 3 Ionis Pharmaceuticals shares in Q1 2022.
Gemmer Asset Management first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 30 quarters.
Gemmer Asset Management's Ionis Pharmaceuticals position peaked at $5K in Q4 2015.
332 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2022.

Based on Gemmer Asset Management's 13F filing for Q1 2022, filed 20 Apr 2022.